Cause-specific mortality and years of life lost in patients with different manifestations of vascular disease

European Journal of Preventive Cardiology

Volumn 23, Issue 2, 2016, Pages 160-169

  Van Kruijsdijk, Rob C M ^a   Van Der Graaf, Yolanda ^a   Koffijberg, Hendrik ^a   De Borst, Gert Jan ^a   Nathoe, Hendrik M ^a   Jaap Kappelle, L ^a   Visseren, Frank L J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiovascular disease; cause of death; competing risks; mortality; years of life lost

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ADULT; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DYING; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL INACTIVITY; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; STANDARDIZED MORTALITY RATIO; VASCULAR DISEASE; AGED; BODY MASS; EPIDEMIOLOGY; MORTALITY; NETHERLANDS;

AGED; BODY MASS INDEX; CAUSE OF DEATH; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NETHERLANDS; SEX FACTORS; SMOKING; VASCULAR DISEASES;

EID: 84953319609     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487314566998     Document Type: Article

References (24)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-2128.
2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012; 125: e2-e220.
3. Nichols M, Townsend N, Scarborough P, et al. Cardiovascular disease in Europe: Epidemiological update. Eur Heart J 2013; 34: 3028-3034.
4. Viles-Gonzalez JF, Fuster V, Badimon JJ,. Atherothrombosis: A widespread disease with unpredictable and life-threatening consequences. Eur Heart J 2004; 25: 1197-1207.
5. Bhatt DL, Eagle KA, Ohman EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 2010; 304: 1350-1357.
6. Bronnum-Hansen H, Davidsen M, Thorvaldsen P,. Long-term survival and causes of death after stroke. Stroke 2001; 32: 2131-2316.
7. Bronnum-Hansen H, Jorgensen T, Davidsen M, et al. Survival and cause of death after myocardial infarction: The Danish MONICA study. J Clin Epidemiol 2001; 54: 1244-1250.
8. Erdem G, Bakhai A, Taneja AK, et al. Rates and causes of death from non-ST elevation acute coronary syndromes: Ten year follow-up of the PRAIS-UK registry. Int J Cardiol 2012; 168: 490-494.
9. Vaartjes I, de Borst GJ, Reitsma JB, et al. Long-term survival after initial hospital admission for peripheral arterial disease in the lower extremities. BMC Cardiovasc Disord 2009; 9: 43-43.
10. van Kruijsdijk RC, van der Graaf Y, Peeters PH, et al. Cancer risk in patients with manifest vascular disease: Effects of smoking, obesity, and metabolic syndrome. Cancer Epidemiol Biomarkers Prev 2013; 22: 1267-1277.
11. van Kruijsdijk RC, van der Wall E, Visseren FL,. Obesity and cancer: The role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009; 18: 2569-2578.
12. Simons PC, Algra A, van de Laak MF, et al. Second manifestations of ARTerial disease (SMART) study: Rationale and design. Eur J Epidemiol 1999; 15: 773-781.
13. World Health Organisation (WHO). WHO international statistical classification of diseases and related health problems. Tenth revision, vol. 2. Geneva, Switzerland: WHO, 1993.
14. Statistics Netherlands. Causes of death; main primary causes of death, age, sex. http://statline.cbs.nl/statweb/?LA=EN (accessed 30 June 2013).
15. Putter H, Fiocco M, Geskus RB,. Tutorial in biostatistics: Competing risks and multi-state models. Stat Med 2007; 26: 2389-2430.
16. Aragon TJ, Lichtensztajn DY, Katcher BS, et al. Calculating expected years of life lost for assessing local ethnic disparities in causes of premature death. BMC Public Health 2008; 8: 116-116.
17. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
18. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
19. Alberts MJ, Bhatt DL, Mas JL, et al. Three-year follow-up and event rates in the international Reduction of Atherothrombosis for Continued Health Registry. Eur Heart J 2009; 30: 2318-2326.
20. Lafeber M, Grobbee DE, Spiering W, et al. The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) in clinical practice in patients with vascular diseases or type 2 diabetes mellitus. Eur J Prev Cardiol 2013; 20: 771-778.
21. El Sakka K, Gambhir RP, Halawa M, et al. Association of malignant disease with critical leg ischaemia. Br J Surg 2005; 92: 1498-1501.
22. Blair SN, Kohl HW 3rd, Paffenbarger RS Jr, et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989; 262: 2395-2401.
23. Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105.
24. Doll R, Peto R, Boreham J, Sutherland I,. Mortality in relation to smoking: 50 Years' observations on male British doctors. Br Med J 2004; 328: 1519-1519.